Enterprise Value

625.9M

Cash

71.52M

Avg Qtr Burn

-10.85M

Short % of Float

24.31%

Insider Ownership

0.69%

Institutional Own.

80.48%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

Cinvanti Details
Chemotherapy induced nausea and vomiting

Approved

Quarterly sales

Sustol Details
Chemotherapy induced nausea and vomiting

Approved

Quarterly sales

Approved

Quarterly sales